PMC Articles for MedGen (Select 449382) - PMC

Links from MedGen

Items: 1 to 20 of 1916

<< First< Prev

Page of 96

Select item 110306681.

IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses

Claudia Falkensammer, Karin Jöhrer, Hubert Gander, Reinhold Ramoner, Thomas Putz, Andrea Rahm, Richard Greil, Georg Bartsch, Martin Thurnher

Cancer Immunol Immunother. 2006 Oct; 55(10): 1228–1237. Published online 2006 Jan 28. doi: 10.1007/s00262-006-0122-1

PMCID:: PMC11030668

Article PDF–755K

Select item 109924402.

Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial

Masaki Shiota, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, Kiyohide Fujimoto, Masahiro Nozawa, Kojiro Ohba, Chikara Ohyama, Katsuyoshi Hashine, Shusuke Akamatsu, Tomomi Kamba, Koji Mita, Momokazu Gotoh, Shuichi Tatarano, Masato Fujisawa, Yoshihiko Tomita, Shoichiro Mukai, Keiichi Ito, Tokiyoshi Tanegashima, Shoji Tokunaga, Masatoshi Eto, SNiP-RCC investigators

Cancer Immunol Immunother. 2023 Jun; 72(6): 1903–1915. Published online 2023 Feb 2. doi: 10.1007/s00262-023-03367-w

PMCID:: PMC10992440

Article PDF–1.0M

Select item 109364693.

Spontaneous and asymptomatic rupture of an RCC with resolution of symptoms

Maaria Chaudhry, Kathleen Botterbush, Justin K Zhang, Jeroen Coppens

BMJ Case Rep. 2024; 17(3): e258534. Published online 2024 Mar 12. doi: 10.1136/bcr-2023-258534

PMCID:: PMC10936469

Article PDF–427K

Select item 109208654.

A comparative analysis of RCC and composite buildings using the new plastic deformation (PD) method

Zhang Qing Qing, Zhang Li Na

Sci Rep. 2024; 14: 5666. Published online 2024 Mar 7. doi: 10.1038/s41598-024-55892-y

PMCID:: PMC10920865

Article PDF–5.1M

Select item 107912795.

Retracted: Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation

Oxidative Medicine and Cellular Longevity

Oxid Med Cell Longev. 2024; 2024: 9846960. Published online 2024 Jan 9. doi: 10.1155/2024/9846960

Retracts:: Oxid Med Cell Longev. 2022; 2022: 9139338.

PMCID:: PMC10791279

Retraction PDF–127K

Select item 107880286.

Predictive value of SIRI and SII for metastases in RCC: a prospective clinical study

Emre Arı, Hikmet Köseoğlu, Tolga Eroğlu

BMC Urol. 2024; 24: 14. Published online 2024 Jan 13. doi: 10.1186/s12894-024-01401-2

PMCID:: PMC10788028

Article PDF–976K

Select item 107792607.

Therapeutic Efficacy of YM155 to Regulate an Epigenetic Enzyme in Major Subtypes of RCC

Seong Hwi Hong, Young Ju Lee, Eun Bi Jang, Hyun Ji Hwang, Eun Song Kim, Da Hyeon Son, Sung Yul Park, Hong Sang Moon, Young Eun Yoon

Int J Mol Sci. 2024 Jan; 25(1): 216. Published online 2023 Dec 22. doi: 10.3390/ijms25010216

PMCID:: PMC10779260

Article PDF–3.6M

Select item 107309838.

A Literature Review of Perioperative Outcomes of Robotic Radical Nephrectomy (RRN) Versus Laparoscopic Radical Nephrectomy (LRN) for Renal Cell Carcinoma (RCC)

Muhannad Alzamzami, Alsamoal Geirbely, Mohamed B Ahmed, Rabab Osman, Rahi Gandhi, Mahmoud Mohammed, Mohammed Elhadi, Ahmed Kodera

Cureus. 2023 Nov; 15(11): e49077. Published online 2023 Nov 19. doi: 10.7759/cureus.49077

PMCID:: PMC10730983

Article PDF–899K

Select item 107181429.

Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma

Tao Wang, Yu Zhou, Hui Bao, Bo Liu, Min Wang, Lei Wang, Tiejun Pan

J Cell Mol Med. 2023 Dec; 27(23): 3897–3910. Published online 2023 Oct 20. doi: 10.1111/jcmm.17972

PMCID:: PMC10718142

Article PDF–23M

Select item 1061236910.

Cavoatrial hypernephroma resection on cardiopulmonary bypass: Mild/normo-versus moderate hypothermia

Andreas Möbius, Philippe Grieshaber, Jan Turra, David Riesterer, Marcin Zaradzki, Petar Soso, Gencay Hatiboglu, Markus Hohenfellner, Gregor Warnecke, Ursula Tochtermann

Perfusion. 2023 Nov; 38(8): 1644–1651. Published online 2022 Sep 20. doi: 10.1177/02676591221128143

PMCID:: PMC10612369

Article PDF–1.0M

Select item 1060792911.

Exploratory Analysis of the Role of Radiomic Features in the Differentiation of Oncocytoma and Chromophobe RCC in the Nephrographic CT Phase

María Aymerich, Alejandra García-Baizán, Paolo Niccolò Franco, Milagros Otero-García

Life (Basel) 2023 Oct; 13(10): 1950. Published online 2023 Sep 23. doi: 10.3390/life13101950

PMCID:: PMC10607929

Article PDF–3.7M

Select item 1044360212.

Giant Renal Cell Carcinoma (RCC): A Case Report of Delayed Diagnosis and Management

Camila A Villacreses, Andrew B Herson, Mitchell C Boshkos, Bailey Beetz, Isaac Elkins, Joseph C Klink

Cureus. 2023 Jul; 15(7): e42324. Published online 2023 Jul 23. doi: 10.7759/cureus.42324

PMCID:: PMC10443602

Article PDF–991K

Select item 1039419813.

Effects of early vs delayed progression on clinical and economic outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first-line therapy: results from the IMPACT RCC claims data analysis

Thomas E Hutson, Frank X Liu, Christopher Dieyi, Ruth Kim, Stan Krulewicz, Vijay Kasturi, Abhijeet Bhanegaonkar

J Manag Care Spec Pharm. 2021 Sep; 27(9): 10.18553/jmcp.2021.20569. doi: 10.18553/jmcp.2021.20569

PMCID:: PMC10394198

Article PDF–314K

Select item 1038050814.

Co-Expression of Multiple PAX Genes in Renal Cell Carcinoma (RCC) and Correlation of High PAX Expression with Favorable Clinical Outcome in RCC Patients

Lei Li, Caiyun G. Li, Suzan N. Almomani, Sultana Mehbuba Hossain, Michael R. Eccles

Int J Mol Sci. 2023 Jul; 24(14): 11432. Published online 2023 Jul 14. doi: 10.3390/ijms241411432

PMCID:: PMC10380508

Article PDF–4.4M

Select item 1034036715.

Oncological and Peri-Operative Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma for Patients with Hereditary RCC Diseases—An Analysis of European Multi-Centre Prospective EuRECA Registry

Filzah Hanis Osman, Vinson Wai-Shun Chan, David J. Breen, Alexander King, Tommy Kjærgaard Nielsen, Julien Garnon, Des Alcorn, Brunolf Lagerveld, Ole Graumann, Francis Xavier Keeley, Jr., Miles Walkden, Éric de Kerviler, Tze Min Wah

Cancers (Basel) 2023 Jul; 15(13): 3322. Published online 2023 Jun 24. doi: 10.3390/cancers15133322

PMCID:: PMC10340367

Article PDF–996K

Select item 1033710916.

The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs

Hilin Yildirim, Christiaan V Widdershoven, Maureen JB Aarts, Axel Bex, Haiko J Bloemendal, Deirdre M Bochove-Overgaauw, Paul Hamberg, Karin H Herbschleb, Tom van der Hulle, Brunolf W Lagerveld, Martijn GH van Oijen, Sjoukje F Oosting, Johannes V van Thienen, Astrid AM van der Veldt, Hans M Westgeest, Evelijn E Zeijdner, Katja KH Aben, Corina van den Hurk, Patricia J Zondervan, Adriaan D Bins

BMC Cancer. 2023; 23: 648. Published online 2023 Jul 11. doi: 10.1186/s12885-023-11094-9

PMCID:: PMC10337109

Article PDF–1006K

Select item 1032748217.

Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis

Kai Xu, Ye Zhang, Zhiwei Yan, Yuchan Wang, Yanze Li, Qiangmin Qiu, Yang Du, Zhiyuan Chen, Xiuheng Liu

Front Immunol. 2023; 14: 1205250. Published online 2023 Jun 23. doi: 10.3389/fimmu.2023.1205250

PMCID:: PMC10327482

Article PDF–23M

Select item 1029531418.

Chasing the Role of miRNAs in RCC: From Free-Circulating to Extracellular-Vesicle-Derived Biomarkers

Ilenia Mastrolia, Virginia Catani, Marco Oltrecolli, Stefania Pipitone, Maria Giuseppa Vitale, Valentina Masciale, Chiara Chiavelli, Carlo Augusto Bortolotti, Cecilia Nasso, Giulia Grisendi, Roberto Sabbatini, Massimo Dominici

Biology (Basel) 2023 Jun; 12(6): 877. Published online 2023 Jun 17. doi: 10.3390/biology12060877

PMCID:: PMC10295314

Article PDF–1.2M

Select item 1029032719.

Free-fatty acid receptor-1 (FFA1/GPR40) promotes papillary RCC proliferation and tumor growth via Src/PI3K/AKT/NF-κB but suppresses migration by inhibition of EGFR, ERK1/2, STAT3 and EMT

Priyanka F. Karmokar, Nader H. Moniri

Cancer Cell Int. 2023; 23: 126. Published online 2023 Jun 24. doi: 10.1186/s12935-023-02967-x

PMCID:: PMC10290327

Article PDF–3.6M

Select item 1020527920.

Endovascular management of RCC in one-kidney patient: a case report study

Amjad Ghareeb, Bairak Salameh, Malaz Halaweh, Muhamad Al-Tawil, Mohammed Ali Nahas

Ann Med Surg (Lond) 2023 May; 85(5): 2108–2111. Published online 2023 Apr 1. doi: 10.1097/MS9.0000000000000559

PMCID:: PMC10205279

Article PDF–439K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 1916

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity